Cerebral metabolism and mood in remitted opiate dependence

Drug Alcohol Depend. 2007 Oct 8;90(2-3):166-74. doi: 10.1016/j.drugalcdep.2007.03.015. Epub 2007 May 22.

Abstract

Background: Opiate-dependent individuals are prone to dysphoria that may contribute to treatment failure. Methadone-maintenance therapy (MMT) may mitigate this vulnerability, but controversy surrounds its long-term use. Little is known about the neurobiology of mood dysregulation in individuals receiving or removed from MMT.

Methods: Fifteen opiate-abstinent and 12 methadone-maintained, opiate-dependent subjects, who lacked other Axis I pathology, and 13 control subjects were compared on the Cornell Dysthymia Rating Scale (CDRS) and regional cerebral glucose metabolism (rCMRglc) using [(18)F]fluorodeoxyglucose positron emission tomography.

Results: CDRS scores showed no group differences. Opiate-abstinent subjects had lower rCMRglc than control subjects in the bilateral perigenual anterior cingulate cortex (ACC), left mid-cingulate cortex, left insula and right superior frontal cortex. Methadone-maintained subjects exhibited lower rCMRglc than control subjects in the left insula and thalamus. In opiate-abstinent subjects, rCMRglc in the left perigenual ACC and mid-cingulate cortex correlated positively with CDRS scores.

Conclusions: In remitted heroin dependence, opiate-abstinence is associated with more widespread patterns of abnormal cortical activity than MMT. Aberrant mood processing in the left perigenual ACC and mid-cingulate cortex, seen in opiate-abstinent individuals, is absent in those receiving MMT, suggesting that methadone may improve mood regulation in this population.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Affect / physiology*
  • Brain / metabolism*
  • Dysthymic Disorder / diagnosis
  • Dysthymic Disorder / epidemiology
  • Dysthymic Disorder / psychology
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Humans
  • Male
  • Methadone / therapeutic use
  • Narcotics / therapeutic use
  • Opioid-Related Disorders / psychology*
  • Opioid-Related Disorders / rehabilitation*
  • Positron-Emission Tomography
  • Radiopharmaceuticals / pharmacokinetics
  • Remission Induction
  • Surveys and Questionnaires

Substances

  • Narcotics
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Methadone